Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
Marksans Pharma Limited, together with its subsidiaries, engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally. The company offers products in the pain management, cardiovascular, central nervous system, anti-diabetic, gastrointestinal, analgesics, upper respiratory, ear care, skincare, anticancer, anti-ulcerative, anti-allergy, antiviral, dietary, cardiac, dermatology, antihistamines, anti-fungal, anti-viral, laxatives, and cold and cough therapeutic areas. Its product portfolio includes plain, enteric-coated, and film coated tablets; soft gelatin and hard capsules; oral liquids; and ointments, as well as creams and liquids. The company provides its products to supermarkets, high street retailers, pharmacy chains, and wholesalers. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.
Key Metrics
as of Sep 2026
Market Cap 14,825 Cr
P/E 28.70
Div Yield 0.28 %
Book Value βΉ66.70
52w High βΉ346.00
52w Low βΉ155.00
Face Value βΉ1.00
Quarterly Results
Rs. Crores Β· hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
841.00
856.00
754.00
720.00
620.00
708.00
682.00
642.00
591.00
560.00
586.00
531.00
500.00
Expenses
628.00
661.00
594.00
576.00
520.00
582.00
543.00
495.00
462.00
450.00
453.00
417.00
398.00
Operating Profit
213.00
195.00
161.00
144.00
100.00
127.00
139.00
147.00
128.00
110.00
133.00
114.00
102.00
OPM %
25.00
23.00
21.00
20.00
16.00
18.00
20.00
23.00
22.00
20.00
23.00
21.00
20.00
Other Income
25.00
35.00
20.00
22.00
6.00
15.00
28.00
0.00
15.00
17.00
5.00
19.00
10.00
Depreciation
25.00
24.00
24.00
27.00
23.00
23.00
21.00
20.00
20.00
21.00
22.00
18.00
14.00
Interest
7.00
6.00
6.00
6.00
6.00
3.00
3.00
3.00
3.00
5.00
3.00
2.00
2.00
Profit before tax
207.00
200.00
151.00
133.00
77.00
116.00
143.00
125.00
120.00
100.00
113.00
114.00
97.00
Tax %
23.00
25.00
25.00
26.00
24.00
22.00
27.00
22.00
26.00
23.00
26.00
26.00
27.00
Net Profit
159.00
149.00
114.00
99.00
58.00
91.00
105.00
98.00
89.00
78.00
83.00
84.00
70.00
EPS in Rs
3.47
3.27
2.50
2.17
1.29
2.00
2.31
2.13
1.96
1.73
1.84
1.84
1.52
Profit & Loss
Annual Β· Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
2,951.00 2,623.00 2,177.00 1,852.00 1,491.00 1,376.00 1,134.00 1,000.00 913.00 767.00 893.00 797.00
Expenses
2,350.00 2,090.00 1,719.00 1,513.00 1,232.00 1,037.00 942.00 868.00 834.00 722.00 757.00 612.00
Operating Profit
601.00 533.00 459.00 340.00 259.00 340.00 192.00 132.00 78.00 45.00 136.00 185.00
OPM %
20.00 20.00 21.00 18.00 17.00 25.00 17.00 13.00 9.00 6.00 15.00 23.00
Other Income
82.00 66.00 50.00 59.00 42.00 7.00 0.00 5.00 8.00 7.00 9.00 3.00
Interest
24.00 12.00 11.00 9.00 8.00 8.00 9.00 10.00 10.00 7.00 10.00 16.00
Depreciation
99.00 83.00 74.00 52.00 45.00 36.00 27.00 23.00 27.00 30.00 28.00 16.00
Profit before tax
561.00 504.00 424.00 338.00 248.00 302.00 157.00 104.00 50.00 15.00 107.00 156.00
Tax %
25.00 24.00 26.00 21.00 25.00 21.00 23.00 23.00 28.00 24.00 23.00 28.00
Net Profit
420.00 383.00 315.00 265.00 187.00 239.00 121.00 80.00 36.00 11.00 83.00 112.00
EPS in Rs
9.22 8.40 6.92 5.88 4.51 5.76 2.95 1.87 0.80 0.22 1.92 2.67
Dividend Payout %
10.00 10.00 9.00 9.00 6.00 4.00 3.00 3.00 6.00 23.00 21.00 4.00
Balance Sheet
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
45.00 45.00 45.00 45.00 41.00 41.00 41.00 41.00 41.00 41.00 41.00 41.00
Reserves
2,978.00 2,422.00 2,020.00 1,700.00 1,161.00 846.00 595.00 502.00 430.00 392.00 401.00 326.00
Borrowings
343.00 322.00 244.00 123.00 111.00 34.00 30.00 100.00 118.00 110.00 100.00 101.00
Other Liabilities
489.00 451.00 372.00 322.00 323.00 307.00 236.00 160.00 142.00 209.00 180.00 207.00
Total Liabilities
3,856.00 3,240.00 2,681.00 2,190.00 1,636.00 1,228.00 902.00 802.00 731.00 752.00 722.00 676.00
Fixed Assets
1,044.00 982.00 776.00 486.00 428.00 309.00 303.00 270.00 279.00 267.00 270.00 166.00
CWIP
59.00 27.00 9.00 10.00 3.00 12.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments
0.00 1.00 27.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Assets
2,753.00 2,230.00 1,869.00 1,694.00 1,205.00 907.00 599.00 533.00 451.00 484.00 452.00 510.00
Total Assets
3,856.00 3,240.00 2,681.00 2,190.00 1,636.00 1,228.00 902.00 802.00 731.00 752.00 722.00 676.00
Cash Flows
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Cash from Operating Activity
458.00 207.00 230.00 237.00 99.00 179.00 233.00 27.00 50.00 14.00 31.00 155.00
Cash from Investing Activity
-249.00 -49.00 -141.00 -259.00 -84.00 -45.00 -60.00 -13.00 -39.00 -21.00 -123.00 -33.00
Cash from Financing Activity
-71.00 -65.00 -69.00 198.00 80.00 -15.00 -114.00 -21.00 3.00 -3.00 -58.00 17.00
Net Cash Flow
138.00 93.00 21.00 176.00 94.00 118.00 60.00 -7.00 15.00 -10.00 -150.00 138.00
Free Cash Flow
329.00 35.00 22.00 184.00 53.00 133.00 174.00 14.00 11.00 -14.00 -101.00 118.00
CFO/OP %
99.00 62.00 77.00 88.00 66.00 67.00 134.00 41.00 73.00 31.00 43.00 108.00
Ratios
Annual Β· Days / % β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Debtor Days
80.00 75.00 76.00 82.00 97.00 72.00 78.00 64.00 71.00 118.00 89.00 84.00
Inventory Days
278.00 270.00 217.00 192.00 216.00 248.00 155.00 215.00 152.00 151.00 120.00 107.00
Days Payable
96.00 98.00 94.00 91.00 102.00 103.00 71.00 78.00 54.00 129.00 85.00 88.00
Cash Conversion Cycle
261.00 247.00 199.00 183.00 211.00 217.00 163.00 202.00 169.00 140.00 124.00 103.00
Working Capital Days
149.00 142.00 129.00 122.00 121.00 104.00 87.00 97.00 70.00 77.00 59.00 17.00
ROCE %
19.00 20.00 21.00 22.00 23.00 38.00 25.00 18.00 10.00 4.00 23.00 44.00
Shareholding Pattern
% holding β latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
43.87
43.87
43.87
43.87
43.87
43.87
43.87
43.87
43.87
43.85
43.85
43.85
FIIs
17.47
16.76
8.13
16.92
19.89
22.19
21.95
21.31
18.59
15.57
15.55
15.07
DIIs
6.19
6.57
5.91
5.28
5.50
4.55
4.30
4.10
3.75
5.17
4.76
4.02
Public
32.46
32.78
42.08
33.93
30.74
29.37
29.88
30.70
33.77
35.40
35.81
37.06
No. of Shareholders
246,635
246,279
255,153
265,788
256,221
257,273
259,813
248,845
235,500
254,699
237,377
207,937
Corporate Actions
25 records
Back to all stocks